Asia: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Asia

The Asian market for other medicaments for therapeutic or prophylactic uses expanded slightly to $X in 2022, surging by X% against the previous year. The total consumption indicated a prominent expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2018 indices. The level of consumption peaked in 2022 and is likely to see gradual growth in years to come.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Asia

In value terms, production of other medicaments for therapeutic or prophylactic uses rose slightly to $X in 2022 estimated in export price. The total production indicated resilient growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The pace of growth was the most pronounced in 2019 when the production volume increased by X% against the previous year. The level of production peaked at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in Asia

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the third consecutive year after two years of decline. In general, exports saw a relatively flat trend pattern. The volume of export peaked at X tons in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022. Overall, exports, however, continue to indicate a slight reduction. Over the period under review, the exports of hit record highs at $X in 2017; however, from 2018 to 2022, the exports remained at a lower figure.

Exports by Country

In 2022, Israel (X tons), Singapore (X tons), China (X tons) and India (X tons) was the main exporter of other medicaments for therapeutic or prophylactic uses in Asia, committing X% of total export. Brunei Darussalam (X tons) and Jordan (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Brunei Darussalam (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, Israel ($X) emerged as the largest other medicaments for therapeutic or prophylactic uses supplier in Asia, comprising X% of total exports. The second position in the ranking was taken by China ($X), with a X% share of total exports. It was followed by Singapore, with a X% share.

In Israel, exports of other medicaments for therapeutic or prophylactic uses contracted by an average annual rate of X% over the period from 2012-2022. The remaining exporting countries recorded the following average annual rates of exports growth: China (X% per year) and Singapore (X% per year).

Export Prices by Country

In 2022, the export price in Asia amounted to $X per ton, picking up by X% against the previous year. In general, the export price, however, showed a slight slump. The most prominent rate of growth was recorded in 2021 when the export price increased by X%. Over the period under review, the export prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Israel ($X per ton), while Brunei Darussalam ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the other leaders experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in Asia

In 2022, purchases abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the third consecutive year after two years of decline. The total import volume increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2016 when imports increased by X% against the previous year. Over the period under review, imports of reached the peak figure at X tons in 2017; however, from 2018 to 2022, imports remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses rose slightly to $X in 2022. The total import value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2019 when imports increased by X%. Over the period under review, imports of reached the peak figure in 2022 and are likely to see steady growth in the near future.

Imports by Country

The purchases of the twelve major importers of other medicaments for therapeutic or prophylactic uses, namely India, China, South Korea, Thailand, Japan, Nepal, Turkey, Malaysia, Bangladesh, Vietnam, Hong Kong SAR and Sri Lanka, represented more than two-thirds of total import. Taiwan (Chinese) (X tons) followed a long way behind the leaders.

From 2012 to 2022, the biggest increases were recorded for China (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest other medicaments for therapeutic or prophylactic uses importing markets in Asia were China ($X), Japan ($X) and Turkey ($X), with a combined X% share of total imports. South Korea, India, Thailand, Hong Kong SAR, Taiwan (Chinese), Nepal, Malaysia, Bangladesh, Vietnam and Sri Lanka lagged somewhat behind, together comprising a further X%.

Bangladesh, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Asia amounted to $X per ton, falling by X% against the previous year. Overall, the import price, however, continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2013 when the import price increased by X% against the previous year. Over the period under review, import prices reached the peak figure at $X per ton in 2020; however, from 2021 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Japan ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Taiwan (Chinese) (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :